208 related articles for article (PubMed ID: 23634936)
1. The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
Porter KE; Riches K
Clin Sci (Lond); 2013 Aug; 125(4):167-82. PubMed ID: 23634936
[TBL] [Abstract][Full Text] [Related]
2. The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro.
Sun X; Han F; Yi J; Hou N; Cao Z
Mol Med Rep; 2013 May; 7(5):1636-40. PubMed ID: 23450462
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.
Riches K; Alshanwani AR; Warburton P; O'Regan DJ; Ball SG; Wood IC; Turner NA; Porter KE
J Mol Cell Cardiol; 2014 Sep; 74(100):240-50. PubMed ID: 24927876
[TBL] [Abstract][Full Text] [Related]
4. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
5. Vascular Smooth Muscle as a Target for Novel Therapeutics.
Porter KE; Riches K
Curr Diab Rep; 2015 Oct; 15(10):72. PubMed ID: 26277484
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease in recent onset diabetes mellitus.
Yamagishi S
J Cardiol; 2011 May; 57(3):257-62. PubMed ID: 21367583
[TBL] [Abstract][Full Text] [Related]
8. Endothelium and vascular smooth muscle cells in the context of uremia.
Günthner T; Jankowski V; Kretschmer A; Nierhaus M; van der Giet M; Zidek W; Jankowski J
Semin Dial; 2009; 22(4):428-32. PubMed ID: 19708995
[TBL] [Abstract][Full Text] [Related]
9. Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.
Cai X
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):789-800. PubMed ID: 17173496
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular smooth muscle cell differentiation.
Rzucidlo EM; Martin KA; Powell RJ
J Vasc Surg; 2007 Jun; 45 Suppl A():A25-32. PubMed ID: 17544021
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular complications in diabetes mellitus.
Sobel BE; Schneider DJ
Curr Opin Pharmacol; 2005 Apr; 5(2):143-8. PubMed ID: 15780822
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
13. Role of MicroRNA-145 in DNA Damage Signalling and Senescence in Vascular Smooth Muscle Cells of Type 2 Diabetic Patients.
Hemmings KE; Riches-Suman K; Bailey MA; O'Regan DJ; Turner NA; Porter KE
Cells; 2021 Apr; 10(4):. PubMed ID: 33923614
[TBL] [Abstract][Full Text] [Related]
14. New frontiers in the management of type 2 diabetes.
Mudaliar S
Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion.
Matchkov VV
Dan Med Bull; 2010 Oct; 57(10):B4191. PubMed ID: 21040688
[TBL] [Abstract][Full Text] [Related]
17. PDE5 inhibitors: targeting erectile dysfunction in diabetics.
Francis SH; Corbin JD
Curr Opin Pharmacol; 2011 Dec; 11(6):683-8. PubMed ID: 21924956
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contribution.
Maegdefessel L; Rayner KJ; Leeper NJ
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):2-6. PubMed ID: 25520518
[No Abstract] [Full Text] [Related]
19. Coronary artery disease and fibrinolysis: from the blood to the vessel wall.
Sobel BE
Thromb Haemost; 1999 Sep; 82 Suppl 1():8-13. PubMed ID: 10695478
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.
Torella D; Iaconetti C; Catalucci D; Ellison GM; Leone A; Waring CD; Bochicchio A; Vicinanza C; Aquila I; Curcio A; Condorelli G; Indolfi C
Circ Res; 2011 Sep; 109(8):880-93. PubMed ID: 21852550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
